Menú

GRenSSAP
GRenSSAP

Group leader
avatar_investigadors.jpg
Anna Berenguera Ossó
avatar_grups_recerca.png

Projectes

Group projects

Post-Authorisation Safety Study of AZD1222. A post-authorisation/post-marketing observational study to evaluate the association between exposure to AZD1222 and safety concerns using existing secondary health data sources

  • Principal investigators: Rosa Morros Pedrós, Maria Giner Soriano
  • Code: 4R21/075
  • Start year: 2021
  • Funders: Research Triangle Institute (RTI)

Retrospective Longitudinal Study on Edoxaban in Patients with Non-Valvular Atrial Fibrillation in Europe

  • Principal investigators: Rosa Morros Pedrós, Maria Giner Soriano
  • Code: 4R21/145
  • Start year: 2021
  • Funders: Syneos Health Consulting INC.

Post-authorisation Safety Study of Rimegepant in Patients with Migraine and History of Cardiovascular Disease in European Countries

  • Principal investigators: Maria Giner Soriano
  • Code: 4R22/026
  • Start year: 2022
  • Funders: Research Triangle Institute (RTI)

Quality, efficacy and safety studies on medicines, Lot 5 Pharmacoepidemiological research (V. HEBRON)

  • Principal investigators: Rosa Morros Pedrós, Maria Giner Soriano
  • Code: 9F21/006
  • Start year: 2021
  • Funders: European Medicines Agency (EMA)

Utilització de fàrmacs Insuficiència Cardíaca

  • Principal investigators: Maria Giner Soriano
  • Code: 4R22/211
  • Start year: 2022
  • Funders: Institut d’Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol)